International Survey from Biogen Identifies Opportunities for Improving MS Treatment Satisfaction

Go back to International Survey from Biogen Identifies Opportunities for Improving MS Treatment Satisfaction
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 199.71 +3.13 (1.59%)
Previous Close $196.58    52 Week High $333.65 
Open $199.48    52 Week Low $223.02 
Day High $200.98    P/E 25.57 
Day Low $194.74    EPS $7.81 
Volume 864,322